Form 8-K - Current report:
SEC Accession No. 0001494650-24-000137
Filing Date
2024-09-25
Accepted
2024-09-25 16:33:24
Documents
14
Period of Report
2024-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20240924.htm   iXBRL 8-K 28221
5 optn-20240924_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-24-000137.txt   177550

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20240924.xsd EX-101.SCH 1904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20240924_lab.xml EX-101.LAB 21689
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20240924_pre.xml EX-101.PRE 12525
16 EXTRACTED XBRL INSTANCE DOCUMENT optn-20240924_htm.xml XML 2722
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 241324995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)